Novel Integration of New prostate radiation therapy schedules with adJuvant Androgen deprivation

In men with intermediate and high-risk prostate cancer, the NINJA trial is looking at comparing two different radiotherapy treatment schedules called stereotactic body radiotherapy (SBRT). The aim is to develop better methods of treatment for prostate cancer using this type of treatment, and further understand what causes some of the side effects of treatments. It is hoped this research will potentially improve the accuracy and quality of radiotherapy treatment in prostate cancer.

Primary Sponsor

Trans Tasman Radiation Oncology Group (TROG)

Collaborating Groups

Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Participating Centres

Accrual Target

472

Current Accrual

Trial Chairperson

Prof Jarad Martin, Calvary Mater Hospital, NSW, Australia
Dr Mark Sidhom, Liverpool Hospital, NSW, Australia

Trial Contact

ninjatrial@calvarymater.org.au

Clinical Trial Registration

Related Post

24 February, 2026

First patient recruited for trial of new imaging modality for lung cancer

LATEST NEWS: 24 February 2026 The first Australian participant

Roland Towning, participant in TROG NINJA trial
3 February, 2026

Roland’s story

Roland TowningPort Stephens, NSW Roland Towning is taking part